Pharmaceutical potential of synthetic and natural pyrrolomycins

Molecules

Volumn 20, Issue 12, 2015, Pages 21658-21671

  Cascioferro, Stella ^a,b   Raimondi, Maria Valeria ^a   Cusimano, Maria Grazia ^a   Raffa, Demetrio ^a   Maggio, Benedetta ^a   Daidone, Giuseppe ^a   Schillaci, Domenico ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Istituto EuroMediterraneo di Scienza e Tecnologia   (Italy)

Author keywords

Antibiofilm agents; Antibiotic resistance; Pentabromopseudilin; Pyoluteorin; Pyrrolomycins

Indexed keywords

ANTIINFECTIVE AGENT; PYRROLE DERIVATIVE; PYRROLOMYCIN A;

ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; BACTERIUM; BIOFILM; CHEMISTRY; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRROLES;

EID: 84954341974     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201219797     Document Type: Review

References (55)

1. Centers of Diseases Control and Prevention. Available online: http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf (accessed on 2 December 2015).
2. Cascioferro, S.; Cusimano, M.G.; Schillaci, D. Antiadhesion agents against Gram-positive pathogens. Future Microbiol. 2014, 9, 1209-1220.
3. Cascioferro, S.; Totsika, M.; Schillaci, D. Sortase A: An ideal target for anti-virulence drug development. Microb. Pathog. 2014, 77C, 105-112.
4. Penesyan, A.; Gillings, M.; Paulsen, I.T. Antibiotic discovery: Combatting bacterial resistance in cells and in biofilm communities. Mol. Basel Switz. 2015, 20, 5286-5298.
5. Cascioferro, S.; Schillaci, D. The Future of Antibiotic: From the Magic Bullet to the Smart Bullet. J. Microb. Biochem. Technol. 2014, 6, e118.
6. Cascioferro, S.; Raffa, D.; Maggio, B.; Raimondi, M.V.; Schillaci, D.; Daidone, G. Sortase A Inhibitors: Recent Advances and Future Perspectives. J. Med. Chem. 2015.
7. Escaich, S. Antivirulence as a new antibacterial approach for chemotherapy. Curr. Opin. Chem. Biol. 2008, 12, 400-408.
8. Gill, E.E.; Franco, O.L.; Hancock, R.E.W. Antibiotic adjuvants: Diverse strategies for controlling drug-resistant pathogens. Chem. Biol. Drug Des. 2015, 85, 56-78.
9. Payne, D.; Tomasz, A. The challenge of antibiotic resistant bacterial pathogens: The medical need, the market and prospects for new antimicrobial agents. Curr. Opin. Microbiol. 2004, 7, 435-438.
10. Stewart, P.S. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J. Med. Microbiol. 2002, 292, 107-113.
11. Yang, L.; Liu, Y.; Wu, H.; Song, Z.; Høiby, N.; Molin, S.; Givskov, M. Combating biofilms. FEMS Immunol. Med. Microbiol. 2012, 65, 146-157.
12. Schillaci, D.; Cascioferro, S. The Re-Discovering of Old Molecules to face the Antibiotic Crisis. J. Microb. Biochem. Technol. 2015, 7, e121.
13. Cassir, N.; Rolain, J.-M.; Brouqui, P. A new strategy to fight antimicrobial resistance: The revival of old antibiotics. Front. Microbiol. 2014, 5, 551.
14. Komura, S.; Kurahashi, K. Partial purification and properties of L-2,4-diaminobutyric acid activating enzyme from a polymyxin E producing organism. J. Biochem. 1979, 86, 1013-1021.
15. Dijkmans, A.C.; Wilms, E.B.; Kamerling, I.M.C.; Birkhoff, W.; Ortiz-Zacarías, N.V.; van Nieuwkoop, C.; Verbrugh, H.A.; Touw, D.J. Colistin: Revival of an Old Polymyxin Antibiotic. Ther. Drug Monit. 2015, 37, 419-427.
16. Theuretzbacher, U.; Paul, M. Revival of old antibiotics: Structuring the re-development process to optimize usage. Clin. Microbiol. Infect. 2015, 21, 878-880.
17. Falagas, M.E.; Vardakas, K.Z.; Roussos, N.S. Trimethoprim/sulfamethoxazole for Acinetobacter spp.: A review of current microbiological and clinical evidence. Int. J. Antimicrob. Agents 2015, 46, 231-241.
18. Burkholder, P.R.; Pfister, R.M.; Leitz, F.H. Production of a pyrrole antibiotic by a marine bacterium. Appl. Microbiol. 1966, 14, 649-653.
19. Laatsch, H.; Renneberg, B.; Hanefeld, U.; Kellner, M.; Pudleiner, H.; Hamprecht, G.; Kraemer, H.P.; Anke, H. Structure-activity relationships of phenyl- and benzoylpyrroles. Chem. Pharm. Bull. 1995, 43, 537-546.
20. Fehér, D.; Barlow, R.; McAtee, J.; Hemscheidt, T.K. Highly Brominated Antimicrobial Metabolites from a Marine Pseudoalteromonas sp. J. Nat. Prod. 2010, 73, 1963-1966.
21. Masuda, K.; Suzuki, K.; Ishida-Okawara, A.; Mizuno, S.; Hotta, K.; Miyadoh, S.; Hara, O.; Koyama, M. Pyrrolomycin group antibiotics inhibit substance P-induced release of myeloperoxidase from human polymorphonuclear leukocytes. J. Antibiot. 1991, 44, 533-540.
22. Bailey, D.M.; Johnson, R.E.; Salvador, U.J. Pyrrole antibacterial agents. 1. Compounds related to pyoluteorin. J. Med. Chem. 1973, 16, 1298-1300.
23. Hughes, C.G.; Rees, A.H. Nitro analogs of pyoluteorins. J. Med. Chem. 1973, 16, 574-576.
24. Parry, R.; Nishinob, S.; Spain, J. Naturally-occurring nitro compounds. Nat. Prod. Rep. 2011, 28, 152-167.
25. Arima, K.; Imanaka, H.; Kousaka, M.; Fukuda, A.; Tamura, G. Studies on pyrrolnitrin, a new antibiotic. I. Isolation and properties of pyrrolnitrin. J. Antibiot. 1965, 18, 201-204.
26. Hamill, R.; Elander, R.; Mabe, J.; Gorman, M. Metabolism of tryptophans by Pseudomonas aureofaciens. V. Conversion of tryptophan to pyrrolnitrin. Antimicrob. Agents Chemother. 1967, 7, 388-396.
27. Gerth, K.; Trowitzsch, W.; Wray, V.; Höfle, G.; Irschik, H.; Reichenbach, H. Pyrrolnitrin from Myxococcus fulvus (Myxobacterales). J. Antibiot. 1982, 35, 1101-1103.
28. Chernin, L.; Brand, A.; Ismailov, L.; Chet, I. Pyrrolnitrin Production by an Enterobacter agglomerans Strain with a Broad Spectrum of Antagonistic Activity towards Fungal and Bacterial Phytopathogens. Curr. Microbiol. 1996, 32, 208-212.
29. El-Banna, N.; Winkelmann, G. Winkelmann Pyrrolnitrin from Burkholderia cepacia: Antibiotic activity against fungi and novel activities against streptomycetes. J. Appl. Microbiol. 1998, 85, 69-78.
30. Di Santo, R.; Costi, R.; Artico, M.; Massa, S.; Lampis, G.; Deidda, D.; Pompei, R. Pyrrolnitrin and related pyrroles endowed with antibacterial activities against Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett. 1998, 8, 2931-2936.
31. Carter, G.T.; Nietsche, J.A.; Goodman, J.J.; Torrey, M.J.; Dunne, T.S.; Borders, D.B.; Testa, R.T. LL-F42248 alpha, a novel chlorinated pyrrole antibiotic. J. Antibiot. 1987, 40, 233-236.
32. Koyama, M.; Kodama, Y.; Tsuruoka, T.; Ezaki, N.; Niwa, T.; Inouye, S. Structure and synthesis of pyrrolomycin A, a chlorinated nitro-pyrrole antibiotic. J. Antibiot. 1981, 34, 1569-1576.
33. Kaneda, M.; Nakamura, S.; Ezaki, N.; Iitaka, Y. Structure of pyrrolomycin B, a chlorinated nitro-pyrrole antibiotic. J. Antibiot. 1981, 34, 1366-1368.
34. Koyama, M.; Ezaki, N.; Tsuruoka, T.; Inouye, S. Structural studies on pyrrolomycins C, D and E. J. Antibiot. 1983, 36, 1483-1489.
35. Ezaki, N.; Koyama, M.; Shomura, T.; Tsuruoka, T.; Inouye, S. Pyrrolomycins C, D and E, new members of pyrrolomycins. J. Antibiot. 1983, 36, 1263-1267.
36. Charan, R.D.; Schlingmann, G.; Bernan, V.S.; Feng, X.; Carter, G.T. Dioxapyrrolomycin biosynthesis in Streptomyces fumanus. J. Nat. Prod. 2006, 69, 29-33.
37. Ezaki, N.; Shomura, T.; Koyama, M.; Niwa, T.; Kojima, M.; Inouye, S.; Ito, T.; Niida, T. New chlorinated nitro-pyrrole antibiotics, pyrrolomycin A and B (SF-2080 A and B). J. Antibiot. 1981, 34, 1363-1365.
38. Schillaci, D.; Petruso, S.; Sciortino, V. 3,4,5,3',5'-Pentabromo-2-(2'-hydroxybenzoyl)pyrrole: A potential lead compound as anti-Gram-positive and anti-biofilm agent. Int. J. Antimicrob. Agents 2005, 25, 338-340.
39. Schillaci, D.; Petruso, S.; Raimondi, M.V.; Cusimano, M.G.; Cascioferro, S.; Scalisi, M.; La Giglia, M.A.; Vitale, M. Pyrrolomycins as potential anti-staphylococcal biofilms agents. Biofouling 2010, 26, 433-438.
40. Schillaci, D.; Petruso, S.; Cascioferro, S.; Raimondi, M.V.; Haagensen, J.A.J.; Molin, S. In vitro anti-Gram-positive and antistaphylococcal biofilm activity of newly halogenated pyrroles related to pyrrolomycins. Int. J. Antimicrob. Agents 2008, 31, 380-382.
41. Charan, R.D.; Schlingmann, G.; Bernan, V.S.; Feng, X.; Carter, G.T. Additional pyrrolomycins from cultures of Streptomyces fumanus. J. Nat. Prod. 2005, 68, 277-279.
42. Ezaki, N.; Koyama, M.; Kodama, Y.; Shomura, T.; Tashiro, K.; Tsuruoka, T.; Inouye, S.; Sakai, S. Pyrrolomycins F1, F2a, F2b and F3, new metabolites produced by the addition of bromide to the fermentation. J. Antibiot. 1983, 36, 1431-1438.
43. Raffa, D.; Maggio, B.; Raimondi, M.V.; Cascioferro, S.; Plescia, F.; Cancemi, G.; Daidone, G. Recent advanced in bioactive systems containing pyrazole fused with a five membered heterocycle. Eur. J. Med. Chem. 2015, 97, 732-746.
44. Maggio, B.; Raimondi, M.V.; Raffa, D.; Plescia, F.; Cascioferro, S.; Cancemi, G.; Tolomeo, M.; Grimaudo, S.; Daidone, G. Synthesis and antiproliferative activity of 3-(2-chloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-(3H)-one. Eur. J. Med. Chem. 2015, 96, 98-104.
45. Wang, Y.; Mitchell-Ryan, S.; Raghavan, S.; George, C.; Orr, S.; Hou, Z.; Matherly, L.H.; Gangjee, A. Novel 5-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase and as potential antitumor agents. J. Med. Chem. 2015, 58, 1479-1493.
46. Whalen, K.E.; Poulson-Ellestad, K.L.; Deering, R.W.; Rowley, D.C.; Mincer, T.J. Enhancement of antibiotic activity against multidrug-resistant bacteria by the efflux pump inhibitor 3,4-dibromopyrrole-2,5-dione isolated from a Pseudoalteromonas sp. J. Nat. Prod. 2015, 78, 402-412.
47. Liu, J.-J.; Zhao, M.-Y.; Zhang, X.; Zhao, X.; Zhu, H.-L. Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents. Mini Rev. Med. Chem. 2013, 13, 1957-1966.
48. Duan, Y.-T.; Wang, Z.-C.; Sang, Y.-L.; Tao, X.-X.; Zhu, H.-L. Exploration of structure-based on imidazole core as antibacterial agents. Curr. Top. Med. Chem. 2013, 13, 3118-3130.
49. Koyama, M.; Kai, F.; Tsuruoka, T.; Miyauchi, K.; Matsumoto, K.; Akita, E.; Inouye, S.; Niida, T. Heterocyclic Compounds and Antibacterial and Antifungal Compositions Containing the Same as Active Ingredients. EP0080051 A2, 1 June 1983.
50. Petruso, S.; Bonanno, S.; Caronna, S.; Ciofalo, M.; Maggio, B.; Schillaci, D. Oxidative halogenation of substituted pyrroles with Cu(II). Part IV. Bromination of 2-(2'-hydroxybenzoyl)pyrrole. A new synthesis of bioactive analogs of monodeoxypyoluteorin. J. Heterocycl. Chem. 1994, 31, 941-945.
51. Schillaci, D.; Maggio, B.; Petruso, S. In vitro activity of synthetic bromo analogs of pyrrolmycins against clinical Staphylococcus aureus strains. Pharmazie 1996, 51, 64.
52. Raimondi, M.V.; Cascioferro, S.; Schillaci, D.; Petruso, S. Synthesis and antimicrobial activity of new bromine-rich pyrrole derivatives related to monodeoxypyoluteorin. Eur. J. Med. Chem. 2006, 41, 1439-1445.
53. Raimondi, M.V.; Schillaci, D.; Petruso, S. Synthesis and anti-staphylococcal activity of new halogenated pyrroles related to Pyrrolomycins F. J. Heterocycl. Chem. 2007, 44, 1407-1411.
54. Trampuz, A.; Zimmerli, W. Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment. Drugs 2006, 66, 1089-1105.
55. Suto, M.J.; Domagala, J.M.; Roland, G.E.; Mailloux, G.B.; Cohen, M.A. Fluoroquinolones: Relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity. J. Med. Chem. 1992, 35, 4745-4750.